Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03744975 · ClinicalTrials.gov registry record · Phase 2

PDD in Type 2 Diabetes w/wo Diastolic Dysfunction

A Phase 2 study of Diabetes Mellitus, Type 2 and Diastolic Dysfunction, sponsored by Mayo Clinic.

Completed
Registry status
Phase 2
Development phase
72
Enrollment target
1
Study location

NCT03744975 is a Phase 2 study of Diabetes Mellitus, Type 2 and Diastolic Dysfunction that has completed, run by Mayo Clinic. The registered enrollment target is 72 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03744975, a Phase 2 study of Diabetes Mellitus, Type 2 and Diastolic Dysfunction, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 2
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

This study will advance the investigator's knowledge of the integrated cardiorenal and humoral physiology in type 2 diabetic patients with and without pre-clinical diastolic dysfunction, and test a novel therapeutic strategy which may prevent a progression to symptomatic Stage C heart failure

Conditions Studied

Diabetes Mellitus, Type 2 Diastolic Dysfunction

Interventions

  • DRUG Placebos
  • DRUG LCZ 696

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2018-05-01
Est. Completion 2025-08-27
Phase Phase 2

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03744975

The ClinicalTrials.gov registry entry for NCT03744975 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Placebos is the first listed.

NCT03744975 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03744975 about?

NCT03744975 is a clinical study titled "PDD in Type 2 Diabetes w/wo Diastolic Dysfunction". This study will advance the investigator's knowledge of the integrated cardiorenal and humoral physiology in type 2 diabetic patients with and without pre-clinical diastolic dysfunction, and test a novel therapeutic strategy which may prevent a progression to symptomatic Stage C heart failure

What is the current status of trial NCT03744975?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 72 participants. The study started on 2018-05-01. Estimated completion is 2025-08-27.

What conditions does trial NCT03744975 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Diastolic Dysfunction.

What interventions are being tested in trial NCT03744975?

The interventions under investigation include: Placebos (DRUG), LCZ 696 (DRUG).

Who is sponsoring clinical trial NCT03744975?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03744975 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus, Type 2

All registered trials for this condition

Diastolic Dysfunction

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.